Outcomes of participants by self-reported impact of CRTI
| Instrumental to retention in hematology research . | No . | Yes . | P . |
|---|---|---|---|
| No. of participants | 71 | 250 | |
| PI federal grant | 14 (19.7) | 53 (21.2) | |
| Loan repayment award | 5 (7.0) | 17 (6.8) | 1.000 |
| Median total publications (IQR) | 0 (0-12) | 8.5 (0-20) | .005 |
| First author | 1 (0-3) | 3 (1-5) | <.001 |
| Senior author | 0 (0-2) | 2 (0-4) | .004 |
| Collaborator | 3 (0-9) | 6 (2-13) | .006 |
| Median invited lectures (IQR) | 0 (0-8) | 0 (0-9) | .610 |
| Promoted | 34 (47.9) | 129 (51.6) | .731 |
| Median percent effort in research (IQR) | 25 (10-58) | 45 (30-70) | <.001 |
| CRTI facilitated career development in research | |||
| No. of participants | 53 | 268 | |
| PI federal grant | 6 (11.3) | 61 (22.8) | .091 |
| Loan repayment grant | 0 (0) | 22 (8.2) | .062 |
| Median total publications (IQR) | 0 (0-0) | 9.5 (0-19) | <.001 |
| First author | 0 (0-1) | 3 (1-5) | <.001 |
| Senior author | 0 (0-1) | 2 (0-4) | <.001 |
| Collaborator | 1 (0-5) | 6 (3-14) | <.001 |
| Median invited lectures (IQR) | 0 (0-0) | 0 (0-9) | .137 |
| Promoted | 22 (41.5) | 141 (52.6) | .185 |
| Median percent effort in research (IQR) | 15 (5-30) | 48 (30-70) | <.001 |
| CRTI allowed better understanding of requirements to succeed in research | |||
| No. of participants | 25 | 296 | |
| PI federal grant | 3 (12.0) | 64 (21.6) | .379 |
| Loan repayment grant | 0 | 22 (7.4) | .317 |
| Median total publications (IQR) | 0 (0-10) | 7 (0-18) | .132 |
| First author | 0 (0-3) | 2 (1-5) | .002 |
| Senior author | 0 (0-2) | 1 (0-3) | .032 |
| Collaborator | 0 (0-8) | 6 (2-13) | .004 |
| Median invited lectures (IQR) | 0 (0-0) | 0 (0-9) | .283 |
| Promoted | 11 (44.0) | 152 (51.4) | .619 |
| Median percent effort in research (IQR) | 40 (10-70) | 40 (25-70) | .320 |
| CRTI increased feeling connected to investigators in hematology | |||
| No. of participants | 32 | 289 | |
| PI federal grant | 6 (18.8) | 61 (21.2) | .935 |
| Loan repayment grant | 0 (0) | 22 (7.6) | .212 |
| Median total publications (IQR) | 0 (0-16) | 7 (0-18) | .372 |
| First author | 1 (0-2) | 2 (1-5) | <.001 |
| Senior author | 0 (0-2) | 1 (0-3) | .112 |
| Collaborator | 3 (0-10) | 5 (2-13) | .074 |
| Median invited lectures (IQR) | 0 (0-1) | 0-(0-9) | .510 |
| Promoted | 13 (40.6) | 150 (51.9) | .306 |
| Median percent effort in research (IQR) | 20 (10-41.3) | 45 (25-70) | <.001 |
| Continue to feel connected to investigators in hematology | |||
| No. of participants | 54 | 267 | |
| PI federal grant | 7 (13.0) | 60 (22.5) | .166 |
| Loan repayment grant | 0 | 22 (8.2) | .059 |
| Median total publications (IQR) | 0 (0-10) | 9 (0-19) | .002 |
| First author | 0 (0-1) | 3 (1-5) | <.001 |
| Senior author | 0 (0-1) | 2 (0-4) | <.001 |
| Collaborator | 2 (0-7) | 6 (2-14) | <.001 |
| Median invited lectures (IQR) | 0 (0-0) | 0 (0-9) | .173 |
| Promoted | 24 (44.4) | 139 (52.1) | .383 |
| Median percent effort in research (IQR) | 17.5 (5-40) | 46 (30-70) | <.001 |
| Instrumental to retention in hematology research . | No . | Yes . | P . |
|---|---|---|---|
| No. of participants | 71 | 250 | |
| PI federal grant | 14 (19.7) | 53 (21.2) | |
| Loan repayment award | 5 (7.0) | 17 (6.8) | 1.000 |
| Median total publications (IQR) | 0 (0-12) | 8.5 (0-20) | .005 |
| First author | 1 (0-3) | 3 (1-5) | <.001 |
| Senior author | 0 (0-2) | 2 (0-4) | .004 |
| Collaborator | 3 (0-9) | 6 (2-13) | .006 |
| Median invited lectures (IQR) | 0 (0-8) | 0 (0-9) | .610 |
| Promoted | 34 (47.9) | 129 (51.6) | .731 |
| Median percent effort in research (IQR) | 25 (10-58) | 45 (30-70) | <.001 |
| CRTI facilitated career development in research | |||
| No. of participants | 53 | 268 | |
| PI federal grant | 6 (11.3) | 61 (22.8) | .091 |
| Loan repayment grant | 0 (0) | 22 (8.2) | .062 |
| Median total publications (IQR) | 0 (0-0) | 9.5 (0-19) | <.001 |
| First author | 0 (0-1) | 3 (1-5) | <.001 |
| Senior author | 0 (0-1) | 2 (0-4) | <.001 |
| Collaborator | 1 (0-5) | 6 (3-14) | <.001 |
| Median invited lectures (IQR) | 0 (0-0) | 0 (0-9) | .137 |
| Promoted | 22 (41.5) | 141 (52.6) | .185 |
| Median percent effort in research (IQR) | 15 (5-30) | 48 (30-70) | <.001 |
| CRTI allowed better understanding of requirements to succeed in research | |||
| No. of participants | 25 | 296 | |
| PI federal grant | 3 (12.0) | 64 (21.6) | .379 |
| Loan repayment grant | 0 | 22 (7.4) | .317 |
| Median total publications (IQR) | 0 (0-10) | 7 (0-18) | .132 |
| First author | 0 (0-3) | 2 (1-5) | .002 |
| Senior author | 0 (0-2) | 1 (0-3) | .032 |
| Collaborator | 0 (0-8) | 6 (2-13) | .004 |
| Median invited lectures (IQR) | 0 (0-0) | 0 (0-9) | .283 |
| Promoted | 11 (44.0) | 152 (51.4) | .619 |
| Median percent effort in research (IQR) | 40 (10-70) | 40 (25-70) | .320 |
| CRTI increased feeling connected to investigators in hematology | |||
| No. of participants | 32 | 289 | |
| PI federal grant | 6 (18.8) | 61 (21.2) | .935 |
| Loan repayment grant | 0 (0) | 22 (7.6) | .212 |
| Median total publications (IQR) | 0 (0-16) | 7 (0-18) | .372 |
| First author | 1 (0-2) | 2 (1-5) | <.001 |
| Senior author | 0 (0-2) | 1 (0-3) | .112 |
| Collaborator | 3 (0-10) | 5 (2-13) | .074 |
| Median invited lectures (IQR) | 0 (0-1) | 0-(0-9) | .510 |
| Promoted | 13 (40.6) | 150 (51.9) | .306 |
| Median percent effort in research (IQR) | 20 (10-41.3) | 45 (25-70) | <.001 |
| Continue to feel connected to investigators in hematology | |||
| No. of participants | 54 | 267 | |
| PI federal grant | 7 (13.0) | 60 (22.5) | .166 |
| Loan repayment grant | 0 | 22 (8.2) | .059 |
| Median total publications (IQR) | 0 (0-10) | 9 (0-19) | .002 |
| First author | 0 (0-1) | 3 (1-5) | <.001 |
| Senior author | 0 (0-1) | 2 (0-4) | <.001 |
| Collaborator | 2 (0-7) | 6 (2-14) | <.001 |
| Median invited lectures (IQR) | 0 (0-0) | 0 (0-9) | .173 |
| Promoted | 24 (44.4) | 139 (52.1) | .383 |
| Median percent effort in research (IQR) | 17.5 (5-40) | 46 (30-70) | <.001 |
Data are n (%), unless otherwise stated.
All self-reported impacts of CRTI are dichotomized as agree or strongly agree vs strongly disagree, disagree, or neutral.
PI, principal investigator; IQR, interquartile range.